CoreWeave reported second-quarter 2026 revenue of $2,575 million, up from $1,212 million a year earlier, and a $626 million net loss, up from $290 million. Operating income swung to a $49 million loss from a $19 million profit, and the company ended the quarter with approximately $104 billion in revenue backlog. The filing contains no new guidance; management said it would provide forward-looking guidance on the earnings call.
Q2 2026 revenue was $2,575 million versus $1,212 million in Q2 2025.
Net loss was $626 million, or $1.14 per share, compared with $290 million, or $0.60 per share, a year earlier.
Operating loss was $49 million, compared with operating income of $19 million in Q2 2025.
Revenue backlog was approximately $104 billion as of June 30, 2026, excluding more than $25 billion of net new commitments added in early Q3.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From CoreWeave, Inc.'s 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$5.13B
+167.9%
$-2.81
—
-22.7%
FY2024
$1.92B
+736.2%
$-4.30
—
-45.1%
FY2023
$229.00M
—
$-3.09
—
-259.4%
Frequently asked questions
When is CoreWeave's next earnings date?
CoreWeave (CRWV) is scheduled to report on Tuesday, November 10, 2026 after the market closes. Analysts expect EPS of $-1.45.
What did CoreWeave earn last quarter?
For the quarter ended Jun 2026, CoreWeave reported diluted EPS of $-1.14 on revenue of $2.58B (+112.5%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.